Email this page
closeSmith & Nephew announces agreement with Coloplast to launch REPLICARE hydrocolloid dressing in Japan
8 September 2008
The Advanced Wound Management division of Smith & Nephew plc (LSE: SN; NYSE:SNN) announced that it has entered into a licence agreement with Coloplast for the Smith & Nephew Wound Management KK business to sell REPLICARE hydrocolloid dressing for the professional wound care market in Japan.
The agreement provides for Coloplast to supply its Comfeel technology hydrocolloid dressings to Smith & Nephew for an initial 3 year period, during which there is the opportunity to further increase the range of products to be sold into Japan.
REPLICARE is a hydrocolloid dressing covered with polyurethane film on its surface. When a hydrocolloid dressing absorbs exudate, it creates a moist wound environment on the wound surface with the hydrophilic polymer turning into a cohesive gel. This dressing is very flexible and can be applied to any part of the body.
REPLICARE has a split back system on the release paper, enabling easy application, even when wearing gloves. The self adhesive nature of the product enables application with a single hand.
Roger Teasdale, Senior Vice President of Smith & Nephew Advanced Wound Care Strategic Business Unit said, "This is an extension of business to a long established relationship that we have had with Coloplast. The use of REPLICARE dressings in Japan will enable us to offer a more complete range of medical dressing solutions to our customers than any of our competitors, providing the best treatment options for wounds to both clinicians and patients."
Enquiries
| Investors | |
| Liz Hewtt | +44 (0)20 7401 7646 |
| Group Director Corporate Affairs | |
| Smith & Nephew |
| Media | |
| Sidonie Myers | +44 (0)1482 673246 |
| Head of Communication | |
| Smith & Nephew Advanced Wound Management | |
| Elisabeth Geday | +45 (0)49 11 19 22 |
| Head of External Relations | |
| Coloplast |
About Smith & Nephew
Smith & Nephew is a global medical technology business, specializing in Orthopaedic Reconstruction, Orthopaedic Trauma and Clinical Therapies, Endoscopy and Advanced Wound Management products. Smith & Nephew is a global leader in arthroscopy and advanced wound management and is one of the leading global orthopaedics companies.
Smith & Nephew is dedicated to helping improve people's lives. The Company prides itself on the strength of its relationships with its surgeons and professional healthcare customers, with whom its name is synonymous with high standards of performance, innovation and trust. The Company operates in 32 countries around the world. Annual sales in 2007 were $3.4 billion.
Forward-Looking Statements
This press release contains certain "forward-looking statements" within the meaning of the US Private Securities Litigation Reform Act of 1995. In particular, statements regarding expected revenue growth and trading margins are forward-looking statements as are discussions of our product pipeline. These statements, as well as the phrases "aim", "plan", "intend", "anticipate", "well-placed", "believe", "estimate", "expect", "target", "consider" and similar expressions, are generally intended to identify forward-looking statements. Such forward-looking statements involve known and unknown risks, uncertainties and other important factors (including, but not limited to, the harmonization of sales practices, the outcome of litigation, claims and regulatory approvals) that could cause the actual results, performance or achievements of Smith & Nephew, or industry results, to differ materially from any future results, performance or achievements expressed or implied by such forward-looking statements. Please refer to the documents that Smith & Nephew has filed with the U.S. Securities and Exchange Commission under the U.S. Securities Exchange Act of 1934, as amended, including Smith & Nephew's most recent annual report on Form 20F, for a discussion of certain of these factors.
All forward-looking statements in this press release are based on information available to Smith & Nephew as of the date hereof. All written or oral forward-looking statements attributable to Smith & Nephew or any person acting on behalf of Smith & Nephew are expressly qualified in their entirety by the foregoing. Smith & Nephew does not undertake any obligation to update or revise any forward-looking statement contained herein to reflect any change in Smith & Nephew's expectation with regard thereto or any change in events, conditions or circumstances on which any such statement is based.